Guidelines

The FDA has issued a revised draft guidance designed to allow for a more efficient approach to 505(q) petitions and allow the agency to focus more reviewer resources on scientific reviews.

Eisai has received the FDA's approval for an expanded indication of Fycompa in pediatric patients age 4 years old and older who have seizures.

The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement will provide a windfall for brand-name drug manufacturers and raise prescription drug prices for patients.

The opioid-abuse-prevention legislation crafted by the Senate and House of Representatives includes four of the policy topics recommended by the National Association of Chain Drug Stores.

Eli Lilly's FDA approval for Emgality is bringing a new preventive treatment of migraine to adults.

The Food and Drug Administration approved Copiktra for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

AstraZeneca's needle-free, nasal spray flu vaccine is available for the upcoming flu season.

Walgreens participated in WE Day UN in New York City on Wednesday by bringing its national ItEndsWithUs opioid abuse and misuse prevention campaign to local students through the event at Barclays Center in Brooklyn.